183 EUR
3
1.61%
Last update Dec 16, 8:00 AM CET
Main market
Day range
183
183
Previous close
186
Open
183
Access this stock data via API
Subscribe
Ascendis Pharma A/S - ADR
183.00
3
1.61%

Financials

Income statement

Fiscal date 2024
Total reported revenue 363.6M
Cost of revenue 44.3M
Gross profit 319.4M
Operating expense
Research & development 307.0M
Selling general and admin 284.5M
Other operating expenses
Operating income -278.8M
Non operating interest income
Income 14.4M
Expense 65.5M
Other income expense -54.6M
Pretax income -373.2M
Tax provision 4.8M
Net income -378.1M
Basic EPS -6.5
Diluted EPS -6.5
Basic average shares 57.9M
Diluted average shares 57.9M
EBITDA -255.5M
Net income from continuing op. -378.1M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 51 minutes

14:08
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).